A plain-language breakdown of the STEP (semaglutide) and SURMOUNT (tirzepatide) Phase 3 clinical trials: design, results, limitations, and what the weight loss percentages really mean for patients.
A plain-language breakdown of the STEP (semaglutide) and SURMOUNT (tirzepatide) Phase 3 clinical trials: design, results, limitations, and what the weight loss percentages really mean for patients.